Rashi Peripherals Q3FY26 Results: Revenue Hits ₹40.30B, Appoints New CEO
Rashi Peripherals delivered strong Q3FY26 results with consolidated revenue of ₹40.30 billion, up 42.61% year-on-year, and net profit of ₹745.94 million, representing 132.60% growth. The company made strategic leadership appointments including Mr. Rajesh Goenka as CEO and approved formation of a UAE subsidiary for ICT distribution.

*this image is generated using AI for illustrative purposes only.
Rashi Peripherals Limited has announced its consolidated financial results for Q3FY26 ended December 31, 2025, demonstrating strong performance across key metrics. The company also made significant leadership appointments and strategic expansion moves during the quarter.
Q3FY26 Financial Performance
The company delivered robust consolidated financial results for the quarter ended December 31, 2025:
| Metric: | Q3FY26 | Q3FY25 | YoY Growth |
|---|---|---|---|
| Consolidated Revenue: | ₹40,304.12 million | ₹28,263.07 million | +42.61% |
| Consolidated Net Profit: | ₹745.94 million | ₹320.70 million | +132.60% |
| Standalone Revenue: | ₹38,044.96 million | ₹26,511.45 million | +43.49% |
| Standalone Net Profit: | ₹702.80 million | ₹308.28 million | +128.02% |
The consolidated revenue of ₹40,304.12 million represents a significant increase from ₹28,263.07 million in the corresponding quarter of the previous year. Net profit after tax surged to ₹745.94 million compared to ₹320.70 million in Q3FY25.
Leadership Appointments
The company announced two key leadership appointments effective February 3, 2026:
| Position: | Details |
|---|---|
| CEO & Whole-Time Director: | Mr. Rajesh Goenka (DIN: 10985108) |
| Term: | 5 years (February 3, 2026 to February 2, 2031) |
| Independent Director: | Dr. Indumati Gopinathan (DIN: 06779331) |
| Tenure: | Until 38th Annual General Meeting |
Mr. Rajesh Goenka brings over 25 years of experience in sales and marketing, having been associated with the company since 2008. Dr. Indumati Gopinathan is an experienced pathologist with leadership roles in healthcare organizations.
Strategic Expansion and Corporate Actions
The company approved the formation of a step-down subsidiary in UAE, which will be wholly-owned by Rashi Peripherals Pte. Ltd. The new entity, Rashi Peripherals LLC, will have authorized capital of UAE Dirham 1,00,000 with investment up to US$ 5,00,000.
| Development: | Details |
|---|---|
| UAE Subsidiary: | Rashi Peripherals LLC |
| Investment: | Up to US$ 5,00,000 |
| Business Focus: | ICT Product Distribution |
| Internal Auditor: | M/s. GMJ & Co. reappointed for FY2026-27 |
IPO Proceeds Utilization
As of December 31, 2025, the company has substantially utilized its IPO proceeds of ₹554.14 crore, with ₹552.53 crore deployed and only ₹1.61 crore remaining unutilized under General Corporate Purposes. The monitoring agency CARE Ratings Limited reported no deviations in fund utilization during the quarter.
Historical Stock Returns for Rashi Peripherals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.50% | +8.02% | +1.15% | +26.13% | +13.25% | +13.51% |
































